Document is current
Any future updates will be listed below
-
Authors
Linares, Isabelle
Chen, Kaihua
Saffren, Ava
Mansouri, Mehran
Abhyankar, Vinay V.
Miller, Benjamin L.
Begolo, Stefano
Awad, Hani A.
McGrath, James L.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UH3TR003281)
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 7 January 2025
First Online: 25 January 2025
Declarations
:
: J.L.M. is a cofounder of SiMPore Inc., the manufacturer of the ultrathin silicon nitride membranes used in this work. S.B. is employed by ALine which is the manufacturer of the components for the hToC. I.L., K.C., A.S., M.M., V.V.A., B.L.M, and H.A.A. declare no potential conflict of interest.
: Monocytes were obtained from healthy donors with informed consent under an IRB-approved protocol at the University of Rochester (STUDY0004777). Tenocytes were isolated from tendon tissues obtained during hand surgeries with informed consent under an IRB-approved protocol at the University of Rochester (STUDY00004840). All methods were performed in accordance with relevant guidelines and regulations.
